Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease

NCT02640339 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02640339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02640339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Completed
Start date
February 29, 2016
Completion date
October 31, 2020
Enrollment
166 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia with lewy bodies, multiple system atrophy, parkinson disease, pure autonomic failure, rem sleep behavior disorder